Neuberger Berman Group LLC Repligen Corp Transaction History

Neuberger Berman Group LLC

  • $123 Billion
  • Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Repligen Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 3,894 shares of RGEN stock, worth $485,698. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,894
Holding current value
$485,698
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$119.79 - $167.35 $53,785 - $75,140
449 Added 13.03%
3,894 $579,000
Q1 2024

Nov 14, 2024
SELL
$170.78 - $208.42 $15.1 Million - $18.4 Million
-88,352 Reduced 96.25%
3,445 $633,000
Q1 2024

May 13, 2024
BUY
$170.78 - $208.42 $588,337 - $718,006
3,445 New
3,445 $633,000
Q4 2023

Nov 14, 2024
BUY
$114.17 - $185.35 $10.5 Million - $17 Million
91,797 New
91,797 $16.5 Million
Q4 2023

Feb 09, 2024
BUY
$114.17 - $185.35 $2.55 Million - $4.14 Million
22,313 Added 32.11%
91,797 $16.5 Million
Q3 2023

Nov 14, 2023
BUY
$138.78 - $176.51 $275,617 - $350,548
1,986 Added 2.94%
69,484 $11 Million
Q2 2023

Aug 11, 2023
BUY
$138.42 - $180.31 $9.09 Million - $11.8 Million
65,687 Added 3627.11%
67,498 $9.55 Million
Q1 2023

May 12, 2023
BUY
$154.26 - $198.1 $2,005 - $2,575
13 Added 0.72%
1,811 $304,000
Q4 2022

Feb 13, 2023
SELL
$162.42 - $220.56 $10,394 - $14,115
-64 Reduced 3.44%
1,798 $304,000
Q3 2022

Nov 15, 2022
BUY
$160.42 - $256.21 $34,490 - $55,085
215 Added 13.05%
1,862 $348,000
Q2 2022

Aug 15, 2022
BUY
$140.68 - $188.02 $231,699 - $309,668
1,647 New
1,647 $267,000
Q3 2021

Nov 12, 2021
SELL
$194.77 - $324.21 $6.85 Million - $11.4 Million
-35,172 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$165.87 - $220.95 $688,194 - $916,721
-4,149 Reduced 10.55%
35,172 $6.96 Million
Q1 2021

May 13, 2021
BUY
$180.37 - $226.26 $2.2 Million - $2.76 Million
12,197 Added 44.97%
39,321 $7.6 Million
Q4 2020

Feb 10, 2021
BUY
$148.08 - $206.57 $591,727 - $825,453
3,996 Added 17.28%
27,124 $5.18 Million
Q3 2020

Nov 12, 2020
BUY
$122.51 - $158.27 $2,450 - $3,165
20 Added 0.09%
23,128 $3.41 Million
Q2 2020

Aug 13, 2020
SELL
$94.33 - $140.48 $185,547 - $276,324
-1,967 Reduced 7.84%
23,108 $2.84 Million
Q1 2020

May 14, 2020
SELL
$84.96 - $109.14 $1.73 Million - $2.22 Million
-20,325 Reduced 44.77%
25,075 $2.42 Million
Q3 2019

Nov 13, 2019
BUY
$76.65 - $95.51 $352,590 - $439,346
4,600 Added 11.27%
45,400 $3.48 Million
Q2 2019

Aug 13, 2019
BUY
$54.2 - $85.95 $856,360 - $1.36 Million
15,800 Added 63.2%
40,800 $3.51 Million
Q1 2019

May 13, 2019
BUY
$49.45 - $62.8 $1.24 Million - $1.57 Million
25,000 New
25,000 $1.48 Million

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email